Correlation Between Arvinas and C4 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Arvinas and C4 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arvinas and C4 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arvinas and C4 Therapeutics, you can compare the effects of market volatilities on Arvinas and C4 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arvinas with a short position of C4 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arvinas and C4 Therapeutics.
Diversification Opportunities for Arvinas and C4 Therapeutics
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Arvinas and CCCC is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Arvinas and C4 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on C4 Therapeutics and Arvinas is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arvinas are associated (or correlated) with C4 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of C4 Therapeutics has no effect on the direction of Arvinas i.e., Arvinas and C4 Therapeutics go up and down completely randomly.
Pair Corralation between Arvinas and C4 Therapeutics
Given the investment horizon of 90 days Arvinas is expected to generate 0.83 times more return on investment than C4 Therapeutics. However, Arvinas is 1.2 times less risky than C4 Therapeutics. It trades about -0.06 of its potential returns per unit of risk. C4 Therapeutics is currently generating about -0.25 per unit of risk. If you would invest 2,712 in Arvinas on August 27, 2024 and sell it today you would lose (197.00) from holding Arvinas or give up 7.26% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Arvinas vs. C4 Therapeutics
Performance |
| Timeline |
| Arvinas |
| C4 Therapeutics |
Arvinas and C4 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Arvinas and C4 Therapeutics
The main advantage of trading using opposite Arvinas and C4 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arvinas position performs unexpectedly, C4 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in C4 Therapeutics will offset losses from the drop in C4 Therapeutics' long position.| Arvinas vs. C4 Therapeutics | Arvinas vs. Monte Rosa Therapeutics | Arvinas vs. Nurix Therapeutics | Arvinas vs. Foghorn Therapeutics |
| C4 Therapeutics vs. Shattuck Labs | C4 Therapeutics vs. Eliem Therapeutics | C4 Therapeutics vs. Prelude Therapeutics | C4 Therapeutics vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |